Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Inc Pfizer currently holds 5,952,263 shares of Allogene Therapeutics, Inc. (ALLO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Inc Pfizer has been a net buyer of ALLO stock. They have purchased $110.7M and sold $6.9M worth of shares.
Inc Pfizer's most recent insider trade was on Aug 1, 2024, when they sold 27,349,211 shares at $45.00 per share.
Inc Pfizer serves as Executive at Allogene Therapeutics, Inc. (ALLO). They have executed 66 insider transactions totaling $117.6M over their tenure at the company.
Inc Pfizer holds the position of Executive at Allogene Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 18 years and currently hold a stake valued at $0.
Inc Pfizer has shown a buying trading pattern, with $110.7M in total purchases and $6.9M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Inc Pfizer was on Aug 1, 2024, when they sold $1.2B worth of CERE shares. This transaction involved 27,349,211 shares at $45.00 per share.
Inc Pfizer currently owns 5,952,263 shares of Allogene Therapeutics, Inc. (ALLO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Inc Pfizer's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Inc Pfizer has 66 Form 4 filings on record as an insider at Allogene Therapeutics, Inc..
Set alerts for Inc Pfizer and 40,000+ other insiders.